Literature DB >> 21151473

Targeted apc;twist double-mutant mice: a new model of spontaneous osteosarcoma that mimics the human disease.

Natacha Entz-Werlé1, Philippe Choquet, Agnès Neuville, Sabine Kuchler-Bopp, François Clauss, Jean-Marc Danse, Pauline Simo-Noumbissie, Eric Guérin, Marie-Pierre Gaub, Jean-Noel Freund, Nelly Boehm, André Constantinesco, Patrick Lutz, Dominique Guenot, Fabienne Perrin-Schmitt.   

Abstract

TWIST and adenomatosis polyposis coli (APC) are critical signaling factors in normal bone development. In previous studies examining a homogeneously treated cohort of pediatric osteosarcoma patients, we reported the frequent and concurrent loss of both TWIST and APC genes. On these bases, we created a related animal model to further explore the oncogenic cooperation between these two genes. We performed intercrosses between twist-null/+ and Apc1638N/+ mice and studied their progeny. The Apc1638N/+;twistnull/+ mice developed bone abnormalities observed by macroscopic skeletal analyses and in vivo imaging. Complementary histologic, cellular, and molecular analyses were used to characterize the identified bone tumors, including cell culture and immunofluorescence of bone differentiation markers. Spontaneous localized malignant bone tumors were frequently identified in Apc1638N/+;twist-null/+ mice by in vivo imaging evaluation and histologic analyses. These tumors possessed several features similar to those observed in human localized osteosarcomas. In particular, the murine tumors presented with fibroblastic, chondroblastic, and osteoblastic osteosarcoma histologies, as well as mixtures of these subtypes. In addition, cellular analyses and bone differentiation markers detected by immunofluorescence on tumor sections reproduced most murine and human osteosarcoma characteristics. For example, the early bone differentiation marker Runx2, interacting physically with hypophosphorylated pRb, was undetectable in these murine osteosarcomas, whereas phosphorylated retinoblastoma was abundant in the osteoblastic and chondroblastic tumor subtypes. These characteristics, similar to those observed in human osteosarcomas, indicated that our animal model may be a powerful tool to further understand the development of localized osteosarcoma.

Entities:  

Year:  2010        PMID: 21151473      PMCID: PMC3000459          DOI: 10.1593/tlo.10169

Source DB:  PubMed          Journal:  Transl Oncol        ISSN: 1936-5233            Impact factor:   4.243


  47 in total

1.  Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation.

Authors:  G Saldanha; V Ghura; L Potter; A Fletcher
Journal:  Br J Dermatol       Date:  2004-07       Impact factor: 9.302

Review 2.  Bone tumor induction after incorporation of short-lived radionuclides.

Authors:  A Luz; W A Müller; U Linzner; P G Strauss; J Schmidt; K Müller; M J Atkinson; A B Murray; W Gössner; V Erfle
Journal:  Radiat Environ Biophys       Date:  1991       Impact factor: 1.925

3.  Analysis of the presence of osteocalcin, S-100 protein, and proliferating cell nuclear antigen in cells of various types of osteosarcomas.

Authors:  T Chano; K Matsumoto; M Ishizawa; S Morimoto; S Hukuda; H Okabe; H Kato; S Fujino
Journal:  Eur J Histochem       Date:  1996       Impact factor: 3.188

4.  A novel orthotopic murine model provides insights into cellular and molecular characteristics contributing to human osteosarcoma.

Authors:  Crispin R Dass; Eugene T Ek; Karla G Contreras; Peter F Choong
Journal:  Clin Exp Metastasis       Date:  2006-12-23       Impact factor: 5.150

5.  Induction of a beta-catenin-LEF-1 complex by wnt-1 and transforming mutants of beta-catenin.

Authors:  E Porfiri; B Rubinfeld; I Albert; K Hovanes; M Waterman; P Polakis
Journal:  Oncogene       Date:  1997-12-04       Impact factor: 9.867

6.  Mutations of the TWIST gene in the Saethre-Chotzen syndrome.

Authors:  V el Ghouzzi; M Le Merrer; F Perrin-Schmitt; E Lajeunie; P Benit; D Renier; P Bourgeois; A L Bolcato-Bellemin; A Munnich; J Bonaventure
Journal:  Nat Genet       Date:  1997-01       Impact factor: 38.330

7.  Tumor-associated Apc mutations in Mlh1-/- Apc1638N mice reveal a mutational signature of Mlh1 deficiency.

Authors:  M Kuraguchi; W Edelmann; K Yang; M Lipkin; R Kucherlapati; A M Brown
Journal:  Oncogene       Date:  2000-11-23       Impact factor: 9.867

8.  Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage.

Authors:  Seth D Berman; Eliezer Calo; Allison S Landman; Paul S Danielian; Emily S Miller; Julie C West; Borel Djouedjong Fonhoue; Alicia Caron; Roderick Bronson; Mary L Bouxsein; Siddhartha Mukherjee; Jacqueline A Lees
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-12       Impact factor: 11.205

9.  TWIST activation by hypoxia inducible factor-1 (HIF-1): implications in metastasis and development.

Authors:  Muh-Hwa Yang; Kou-Juey Wu
Journal:  Cell Cycle       Date:  2008-05-21       Impact factor: 4.534

10.  Control of cell cycle gene expression in bone development and during c-Fos-induced osteosarcoma formation.

Authors:  A Sunters; J McCluskey; A E Grigoriadis
Journal:  Dev Genet       Date:  1998
View more
  11 in total

Review 1.  Molecular genetics of osteosarcoma.

Authors:  Kirby Rickel; Fang Fang; Jianning Tao
Journal:  Bone       Date:  2016-10-17       Impact factor: 4.398

2.  Preclinical mouse models of osteosarcoma.

Authors:  Özge Uluçkan; Aude Segaliny; Sander Botter; Janice M Santiago; Anthony J Mutsaers
Journal:  Bonekey Rep       Date:  2015-05-06

3.  Prognostic value of Twist and E-cadherin in patients with osteosarcoma.

Authors:  Ke Yin; Qiande Liao; Hongbo He; Da Zhong
Journal:  Med Oncol       Date:  2012-07-31       Impact factor: 3.064

4.  Gallic acid induces the apoptosis of human osteosarcoma cells in vitro and in vivo via the regulation of mitogen-activated protein kinase pathways.

Authors:  Cheng-zhen Liang; Xin Zhang; Hao Li; Yi-qing Tao; Li-jiang Tao; Zi-ru Yang; Xiao-peng Zhou; Zhong-li Shi; Hui-min Tao
Journal:  Cancer Biother Radiopharm       Date:  2012-07-31       Impact factor: 3.099

Review 5.  Research models and mesenchymal/epithelial plasticity of osteosarcoma.

Authors:  Xiaobin Yu; Jason T Yustein; Jianming Xu
Journal:  Cell Biosci       Date:  2021-05-22       Impact factor: 7.133

Review 6.  Small animal models for the study of bone sarcoma pathogenesis:characteristics, therapeutic interests and limitations.

Authors:  Camille Jacques; Nathalie Renema; Frederic Lezot; Benjamin Ory; Carl R Walkley; Agi E Grigoriadis; Dominique Heymann
Journal:  J Bone Oncol       Date:  2018-02-21       Impact factor: 4.072

7.  Genetically engineered mouse models and human osteosarcoma.

Authors:  Alvin Jm Ng; Anthony J Mutsaers; Emma K Baker; Carl R Walkley
Journal:  Clin Sarcoma Res       Date:  2012-10-04

8.  TWIST interacts with endothelin-1/endothelin A receptor signaling in osteosarcoma cell survival against cisplatin.

Authors:  Yong Zhou; Xiaofang Zang; Zufa Huang; Chaoyue Zhang
Journal:  Oncol Lett       Date:  2013-01-07       Impact factor: 2.967

Review 9.  Animal models in osteosarcoma.

Authors:  Maria V Guijarro; Steven C Ghivizzani; C Parker Gibbs
Journal:  Front Oncol       Date:  2014-07-18       Impact factor: 6.244

Review 10.  Understanding the Osteosarcoma Pathobiology: A Comparative Oncology Approach.

Authors:  Jyotika Varshney; Milcah C Scott; David A Largaespada; Subbaya Subramanian
Journal:  Vet Sci       Date:  2016-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.